Partners HealthCare to fully integrate its EHR system with MassPAT
Category: #health  By Mateen Dalal  Date: 2019-03-16
  • share
  • Twitter
  • Facebook
  • LinkedIn

Partners HealthCare to fully integrate its EHR system with MassPAT

Partners Healthcare has now become the first healthcare network to have the tool immediately available to doctors at the point-of-care in Massachusetts.

Partners HealthCare, the Boston-based non-profit hospital and physicians network, has reportedly declared that it has fully-integrated with the Commonwealth of Massachusetts’ Prescription Awareness Tool (MassPAT) in its EHR (electronic health record) system.

Reportedly, Partners Healthcare has now become the first healthcare network to have the tool immediately available to doctors at the point-of-care in Massachusetts.

Commissioner of Public Health, Massachusetts, Monica Bharel, MD, MPH, was reportedly quoted saying that a vital aspect of preventing over-prescription of opioids has ensured providers have an accurate detail of prescription history of patients. MassPAT is a crucial aspect of the Commonwealth’s strategy to connect and support healthcare providers and having the Partners HealthCare system focused and fully integrated on ensuring that clinicians get access to the tool which would be a significant advancement in the collective efforts of both the firms to prevent the opioid epidemic, Bharel further added.

According to a press release by Partners HealthCare, Massachusetts Governor Charlie Baker had inked the historic legislation which created MassPAT in the year 2016. The state was one of the firsts in the country to instruct that all prescribers verify the prescription drug monitoring program (PDMP) before prescribing Schedule III or II substances and enforce a limit of seven days on first-time opioids prescriptions to patients.

Chief Quality and Safety Officer at Partners HealthCare, Thomas Sequist, MD, MPH, reportedly commented that the firm is equipping its providers with more strong point-of-care access to the prescription drug monitoring program of the state to support responsible and safe treatment of pain and better manage substance abuse disorder. Providers of Partners HealthCare are better informed about their patient’s medication use by examining the prescription information of patients in MassPAT and can prevent duplication of drug therapies and can further coordinate care by interacting with other prescribers to enhance clinical outcomes, Sequist further added.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Microsoft to fix an active security flaw in Internet Explorer
Microsoft to fix an active security flaw in Internet Explorer
By Mateen Dalal

Microsoft, the renowned American tech giant, reportedly verified the presence of a security flaw that is affecting Internet Explorer (IE) and is being used by hackers. The company also said it is working to find a fix for this bug, which would be rel...

Dermtech signs a commercial & medicare advantage coverage agreement
Dermtech signs a commercial & medicare advantage coverage agreement
By Mateen Dalal

DermTech Inc., a San Diego based biotechnology company that is involved in precision dermatology, has recently announced signing a contract with a regional health plan to develop its gene expression based PLA (Pigmented Lesion Assay) for prior detect...

CoImmune Inc. inks all-stock merger deal with Formula Pharmaceutical
CoImmune Inc. inks all-stock merger deal with Formula Pharmaceutical
By Mateen Dalal

The merger will bring two therapeutic immune-oncology platforms together Focus shall be placed over Phase 1 and Phase 2 trials of CAR-CIK and CMN-001 respectively U.S.-based bioscience firm CoImmune, Inc., announces partnership with Formula Phar...